Prognostic value of ctDNA-derived maximum somatic allele frequency in patients with metastatic gastric cancer
Background: Metastatic gastric cancer (GC) is biologically heterogeneous; however, current staging classifies all metastatic cases as stage IV without reflecting this variability. Circulating tumor DNA (ctDNA)-derived biomarkers, including maximum somatic allele frequency (MSAF), may serve as surrog...
Сохранить в:
| Главные авторы: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publishing
2026-01-01
|
| Серии: | Therapeutic Advances in Medical Oncology |
| Online-ссылка: | https://doi.org/10.1177/17588359251414103 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|